View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Noble Life Sciences
23 March 2021

Fireside Chat: Development of Countermeasures for Viral Diseases

The best defences against viral infectious diseases are safe and effective medical countermeasures that function at the level of prevention of infection (prophylaxis) and treatment of disease (therapeutic). These include microbicides and vaccines, direct-acting antivirals and immunotherapies. This fireside chat will focus on features and characteristics of effective countermeasures, how they defend against viral infection and disease, and the preclinical development pathways to advance them from bench to bedside.


  • Todd Parsley, PhD – Director of Preclinical Research – Infectious Diseases, Noble Life Sciences
  • Aarthi Narayanan, PhD – Associate Professor, National Centre for Biodefence and Infectious Diseases, George Mason University


Date: 31 March 2021

Time: 1:00pm EST

Registration Link: Please click here.

Diabetes is confirmed by both an absence of insulin and increase in blood glucose levels.
Skin serves as a barrier between the external environment and the underlying tissues. When the integrity of the skin is disrupted this barrier is compromised.
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Clinical Trials Arena